《依那卡塞在曾接受西那卡塞治疗的继发性甲状旁腺功能亢进患者中的疗效》勘误，[2021年；https://doi.org/10.1016/j.ekir.2021.08.020] 。
Corrigendum to "Efficacy of evocalcet in previously cinacalcet-treated secondary hyperparathyroidism patients," [ 2021; https://doi.org/10.1016/j.ekir.2021.08.020].
作者信息
Koiwa Fumihiko, Tokunaga Shin, Asada Shinji, Endo Yuichi, Fukagawa Masafumi, Akizawa Tadao
机构信息
Division of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Medical Affairs Department, Kyowa Kirin Co., Ltd., Tokyo, Japan.
出版信息
Kidney Int Rep. 2021 Nov 5;6(11):2936-2937. doi: 10.1016/j.ekir.2021.09.011. eCollection 2021 Nov.
Abstract
[This corrects the article DOI: 10.1016/j.ekir.2021.08.020.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.ekir.2021.08.020。]
相似文献
1
Corrigendum to "Efficacy of evocalcet in previously cinacalcet-treated secondary hyperparathyroidism patients," [ 2021; https://doi.org/10.1016/j.ekir.2021.08.020].《依那卡塞在曾接受西那卡塞治疗的继发性甲状旁腺功能亢进患者中的疗效》勘误，[2021年；https://doi.org/10.1016/j.ekir.2021.08.020] 。
Kidney Int Rep. 2021 Nov 5;6(11):2936-2937. doi: 10.1016/j.ekir.2021.09.011. eCollection 2021 Nov.
2
Corrigendum to "The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients" [Kidney Int. Rep. 2020 1416-1421].《中国血液透析患者中 SARS-CoV-2 感染的累积率》[《肾脏国际报告》2020 年第 1416 - 1421 页]勘误
Kidney Int Rep. 2021 Sep;6(9):2525. doi: 10.1016/j.ekir.2021.07.021. Epub 2021 Sep 2.
3
Corrigendum to "Transjugular Kidney Biopsy as a Safe Method to Increase the Etiological Diagnosis in Kidney Disease" 2021;6:2535-2536.《经颈静脉肾活检：一种增加肾脏疾病病因诊断的安全方法》勘误 2021 年；6：2535 - 2536。
Kidney Int Rep. 2021 Oct 20;6(12):3095. doi: 10.1016/j.ekir.2021.10.013. eCollection 2021 Dec.
4
Corrigendum to "Narita I. Estimating Growth Rate by a Single Measurement of Kidney Volume in ADPKD." . 2020;5:1383-1384.《多囊肾病中通过单次测量肾脏体积估算生长速率》勘误。2020年；5：1383 - 1384。
Kidney Int Rep. 2021 Feb 10;6(2):552. doi: 10.1016/j.ekir.2020.11.012. eCollection 2021 Feb.
5
Corrigendum to "Vimala, A. Hyponatremia among patients admitted in critical care unit at tertiary care hospitals." . 2020;5:S230.《维玛拉，A. 三级护理医院重症监护病房患者低钠血症》勘误。2020年；5：S230。
Kidney Int Rep. 2020 May 11;5(6):959. doi: 10.1016/j.ekir.2020.05.002. eCollection 2020 Jun.
6
Corrigendum to "Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in Developed Countries." 2020;5:263-277.《“Luyckx VA、Cherney DZI、Bello AK。发达国家慢性肾脏病的预防”》勘误。2020年；5：263 - 277。
Kidney Int Rep. 2020 May 4;5(5):758. doi: 10.1016/j.ekir.2020.03.021. eCollection 2020 May.
7
Corrigendum to "Successful Urine Multiplex Bead Assay to Measure Lupus Nephritis Activity" 2021;6:1949-1960.《用于测量狼疮性肾炎活动度的尿液多重微珠检测法的勘误》2021年；6：1949 - 1960。
Kidney Int Rep. 2021 Aug 31;6(10):2735. doi: 10.1016/j.ekir.2021.08.023. eCollection 2021 Oct.
8
Corrigendum to "Kimura T, Snijder R, Nozaki K. Diagnosis patterns of CKD and anemia in the Japanese population." . 2020;5:694-705.《木村T、斯奈德R、野崎K。日本人群中慢性肾脏病和贫血的诊断模式》勘误。2020年；5:694 - 705。
Kidney Int Rep. 2020 Sep 3;5(9):1614. doi: 10.1016/j.ekir.2020.08.006. eCollection 2020 Sep.
9
Corrigendum to Davies SJ, Zhao J, Morgenstern H, et al. Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis-International Results from PDOPPS. 2021;6:313-324.戴维斯 SJ、赵 J、摩根斯特恩 H 等人的《腹膜透析中低血清钾水平与临床结局——国际腹膜透析前瞻性观察性研究（PDOPPS）结果》勘误。2021 年；6：313 - 324。
Kidney Int Rep. 2021 Mar 11;6(5):1485. doi: 10.1016/j.ekir.2021.03.873. eCollection 2021 May.
10
Corrigendum to Shi M, Yu S, Ouyang Y, et al. Increased lifetime risk of ESRD in familial IgA nephropathy. 2021;6:91-100.对Shi M、Yu S、Ouyang Y等人的勘误：家族性IgA肾病患者终末期肾病终生风险增加。2021年；6：91 - 100。
Kidney Int Rep. 2021 Mar 11;6(5):1484. doi: 10.1016/j.ekir.2021.03.871. eCollection 2021 May.
Zotero 插件